Arsenic is more potent than cadmium or manganese in disrupting the INS-1 beta cell microRNA landscape.


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
11 2019
Historique:
received: 22 05 2019
accepted: 17 09 2019
pubmed: 27 9 2019
medline: 28 8 2020
entrez: 27 9 2019
Statut: ppublish

Résumé

Diabetes is a metabolic disorder characterized by fasting hyperglycemia and impaired glucose tolerance. Laboratory and population studies have shown that inorganic arsenic (iAs) can impair these pathways. Other metals including cadmium (Cd) and manganese (Mn) have also been linked to diabetes phenotypes. MicroRNAs, short non-coding RNAs that regulate gene expression, have emerged as potential drivers of metabolic dysfunction. MicroRNAs responsive to metal exposures in vitro have also been reported in independent studies to regulate insulin secretion in vivo. We hypothesize that microRNA dysregulation may associate with and possibly contribute to insulin secretion impairment upon exposure to iAs, Cd, or Mn. We exposed insulin secreting rat insulinoma cells to non-cytotoxic concentrations of iAs (1 µM), Cd (5 µM), and Mn (25 µM) for 24 h followed by small RNA sequencing to identify dysregulated microRNAs. RNA sequencing was then performed to further investigate changes in gene expression caused by iAs exposure. While all three metals significantly inhibited glucose-stimulated insulin secretion, high-throughput sequencing revealed distinct microRNA profiles specific to each exposure. One of the most significantly upregulated microRNAs post-iAs treatment is miR-146a (~ + 2-fold), which is known to be activated by nuclear factor κB (NF-κB) signaling. Accordingly, we found by RNA-seq analysis that genes upregulated by iAs exposure are enriched in the NF-κB signaling pathway and genes down-regulated by iAs exposure are enriched in miR-146a binding sites and are involved in regulating beta cell function. Notably, iAs exposure caused a significant decrease in the expression of Camk2a, a calcium-dependent protein kinase that regulates insulin secretion, has been implicated in type 2 diabetes, and is a likely target of miR-146a. Further studies are needed to elucidate potential interactions among NF-kB, miR-146a, and Camk2a in the context of iAs exposure.

Identifiants

pubmed: 31555879
doi: 10.1007/s00204-019-02574-8
pii: 10.1007/s00204-019-02574-8
pmc: PMC8356444
mid: NIHMS1540604
doi:

Substances chimiques

Arsenites 0
MIRN146a microRNA, rat 0
MicroRNAs 0
NF-kappa B 0
Cadmium 00BH33GNGH
Manganese 42Z2K6ZL8P
Proinsulin 9035-68-1
Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17
Camk2a protein, rat EC 2.7.11.17
arsenite N5509X556J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3099-3109

Subventions

Organisme : NIGMS NIH HHS
ID : 5T32 GM007092
Pays : United States
Organisme : NIH HHS
ID : R01DK105965
Pays : United States
Organisme : UNC Superfund by NIEHS
ID : 3P42ES005948-22S2
Pays : International
Organisme : NIGMS NIH HHS
ID : T32 GM007092
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01ES022697
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES022697
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES005948
Pays : United States

Références

Nat Commun. 2015 Oct 15;6:8640
pubmed: 26468775
Met Ions Biol Med. 2008;10:1-7
pubmed: 20467584
Diabetes. 2000 Mar;49(3):424-30
pubmed: 10868964
PLoS One. 2013;8(2):e54374
pubmed: 23405080
Environ Health Perspect. 2016 Dec;124(12):1876-1881
pubmed: 27258818
Environ Sci Technol. 2018 Dec 18;52(24):14487-14495
pubmed: 30457847
BMC Genomics. 2013 Apr 18;14:264
pubmed: 23597149
Int J Toxicol. 2011 Aug;30(4):410-8
pubmed: 21705745
Diabetes Care. 2003 Feb;26(2):468-70
pubmed: 12547882
J Biol Chem. 2014 May 2;289(18):12435-45
pubmed: 24627477
J Am Soc Nephrol. 2016 Aug;27(8):2277-88
pubmed: 26647423
Diabetes. 2017 Jul;66(7):1819-1832
pubmed: 28411267
Nature. 2009 Jul 23;460(7254):479-86
pubmed: 19536157
Bioinformatics. 2010 Oct 1;26(19):2438-44
pubmed: 20709693
Sci Rep. 2014 Nov 04;4:6894
pubmed: 25367288
Exp Ther Med. 2017 Mar;13(3):815-820
pubmed: 28450904
Cell Metab. 2005 Sep;2(3):153-63
pubmed: 16154098
Nature. 2011 Jun 08;474(7353):649-53
pubmed: 21654750
Mol Metab. 2014 Apr 15;3(4):484-9
pubmed: 24944908
J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):257-63
pubmed: 27087124
Diabetologia. 2011 Jun;54(6):1273-90
pubmed: 21442161
Arch Toxicol. 2018 Feb;92(2):693-704
pubmed: 28956099
J Epidemiol Community Health. 2014 Feb;68(2):176-84
pubmed: 24133074
Nature. 2004 Nov 11;432(7014):226-30
pubmed: 15538371
J Biol Chem. 2013 Apr 12;288(15):10923-35
pubmed: 23426361
Diabetes. 1999 May;48(5):1006-12
pubmed: 10331404
Physiol Rev. 2005 Oct;85(4):1255-70
pubmed: 16183912
Environ Health. 2011 Aug 24;10:73
pubmed: 21864395
J Neuroinflammation. 2014 May 16;11:90
pubmed: 24886705
Diabetes Care. 2015 Apr;38(4):620-7
pubmed: 25583752
Am J Epidemiol. 2012 Nov 15;176(10):865-74
pubmed: 23097256
Diabetes. 2018 Feb;67(2):256-264
pubmed: 29101219
PLoS One. 2013;8(3):e58655
pubmed: 23516528
J Korean Med Sci. 2013 Jun;28(6):861-8
pubmed: 23772150
Diabetes. 2017 Dec;66(12):3029-3040
pubmed: 28970284
Arch Biochem Biophys. 2015 Oct 1;583:27-35
pubmed: 26253262
Arch Toxicol. 2017 Jan;91(1):189-202
pubmed: 26883664
Arch Toxicol. 2018 Jun;92(6):1925-1937
pubmed: 29721587
Toxicol Appl Pharmacol. 2013 Feb 15;267(1):11-5
pubmed: 23261974
Nat Med. 2015 Jun;21(6):619-27
pubmed: 25985365
Bioinformatics. 2012 Jan 1;28(1):105-11
pubmed: 22080467
Int J Mol Cell Med. 2017 Summer;6(3):156-163
pubmed: 29682487
Toxicol Appl Pharmacol. 2008 Sep 15;231(3):291-9
pubmed: 18597805
Arch Toxicol. 2017 Jul;91(7):2617-2627
pubmed: 27847981
Environ Health Perspect. 2012 Dec;120(12):1658-70
pubmed: 22889723
PLoS One. 2017 Mar 16;12(3):e0173918
pubmed: 28301595
JAMA. 2007 May 2;297(17):1901-8
pubmed: 17473300
Diabetes. 2010 Apr;59(4):978-86
pubmed: 20086228
Nucleic Acids Res. 2008 Jan;36(Database issue):D646-50
pubmed: 17965090
Biosystems. 1998 Jun-Jul;47(1-2):119-28
pubmed: 9715755
Biomed Environ Sci. 2017 Jul;30(7):482-491
pubmed: 28756807
J Nutr. 1984 Aug;114(8):1438-46
pubmed: 6379130
Diabetes. 2014 Dec;63(12):4206-17
pubmed: 25028525
Environ Health Perspect. 2016 Jan;124(1):104-11
pubmed: 26068977
PLoS One. 2009 Dec 30;4(12):e8509
pubmed: 20041157
Environ Pollut. 2016 Mar;210:1-8
pubmed: 26689646
Biomed Res Int. 2015;2015:368087
pubmed: 26000288
Biomed Res Int. 2017;2017:2501578
pubmed: 28303247
Am J Physiol. 1983 Nov;245(5 Pt 1):G628-34
pubmed: 6638186
ALTEX. 2010;27(2):105-13
pubmed: 20686743
Diabetes. 2007 Feb;56(2):431-7
pubmed: 17259388
Biochem Biophys Res Commun. 2012 Sep 21;426(2):266-72
pubmed: 22940552
Arch Toxicol. 2019 Sep;93(9):2525-2533
pubmed: 31332465
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
pubmed: 16885212
Toxicol Lett. 2018 Dec 15;299:137-144
pubmed: 30300733
Environ Health Perspect. 2015 May;123(5):399-411
pubmed: 25616258
Islets. 2012 Nov-Dec;4(6):405-16
pubmed: 23466887
Nat Struct Mol Biol. 2011 Feb;18(2):237-44
pubmed: 21258322

Auteurs

Rowan Beck (R)

Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA.

Mohit Chandi (M)

Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.

Matt Kanke (M)

Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA.

Miroslav Stýblo (M)

Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.

Praveen Sethupathy (P)

Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA. pr46@cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH